Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Gijsen

Henricu Jacobus Maria Gijsen, Breda NL

Patent application numberDescriptionPublished
20120022090NOVEL SUBSTITUTED BENZOXAZOLE, BENZIMIDAZOLE, OXAZOLOPYRIDINE AND IMIDAZOPYRIDINE DERIVATIVES AS GAMMA SECRETASE MODULATORS - The present invention is concerned with novel substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives of Formula (I)01-26-2012

Henricus Jacobus Maria Gijsen, Breda BE

Patent application numberDescriptionPublished
20100273773DIBENZOAZEPINE AND DIBENZOOXAZEPINE TRPA1 AGONISTS - The present invention is related to novel tricyclic compounds of formula (I) having TRPA1 receptor agonistic properties, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use as pharmacological tools, or as irritant incapacitants, or in the treatment of diseases linked to the modulation of the TRPA1 receptors in animals, in particular humans.10-28-2010
20100273831FLUORO ALKYL SUBSTITUTED BENZIMIDAZOLE CANNABINOID AGONISTS - The present invention is related to novel benzimidazole compounds of formula (I) having cannabinoid receptor agonistic properties, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals, in particular humans.10-28-2010
20110237580SUBSTITUTED BICYCLIC IMIDAZOLE DERIVATIVES AS GAMMA SECRETASE MODULATORS - The present invention is concerned with novel substituted bicyclic imidazole derivatives of Formula (I)09-29-2011

Henricus Jacobus Maria Gijsen, Beerse BE

Patent application numberDescriptionPublished
20090312339BENZIMIDAZOLE CANNABINOID AGONISTS BEARING A SUBSTITUTED HETEROCYCLIC GROUP - The present invention is related to novel benzimidazole compounds of formula (I) having cannabinoid receptor agonistic properties, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals, in particular humans.12-17-2009
20100087483Aminosulfonyl Substituted 4-(Aminomethyl)-Piperidine Benzamides As 5HT 4-Antagonists - The present invention is concerned with novel compounds of formula (I) having 5HT04-08-2010

Henricus Jacobus Maria Gijsen, Breda NL

Patent application numberDescriptionPublished
20100041702BENZIMIDAZOLE CANNABINOID AGONISTS - The present invention is related to novel benzimidazole compounds of Formula (I) having cannabinoid receptor agonistic properties, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals, in particular humans.02-18-2010
201101246663,4-DIHYDROPYRIMIDINE TRPA1 ANTAGONISTS - The present invention is related to novel 3,4-dihydropyrimidine compounds of formula (I) having TRPA1 receptor antagonistic properties, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment of diseases linked to the modulation of the TRPA1 receptors in animals, in particular humans.05-26-2011
20110281881NOVEL SUBSTITUTED BICYCLIC HETEROCYCLIC COMPOUNDS AS GAMMA SECRETASE MODULATORS - The present invention is concerned with substituted bicyclic heterocyclic compounds of Formula (I)11-17-2011

Patent applications by Henricus Jacobus Maria Gijsen, Breda NL

Rupertus Mattias Rafaƫl Gijsen, Zennewijnen NL

Patent application numberDescriptionPublished
20120070400METHOD FOR IMPROVING THE MILDNESS OF CLEANSING COMPOSITIONS - A method for improving the mildness of a cleansing composition includes 0.1 to 15 wt. % of a combination of a lactate salt and a gluconate salt is provided in a cleansing composition comprising 4-55 wt. % of a surfactant and water, wherein the lactate salt makes up 10-90 wt. % of the total of the lactate salt and the gluconate salt, the lactate salt being selected from one or more of sodium lactate, potassium lactate, ammonium lactate, calcium lactate, and triethanolamine lactate and the gluconate salt being selected from one or more of sodium gluconate, potassium gluconate, ammonium gluconate, calcium gluconate, and triethanolamine gluconate. The A cleansing composition, a method for the manufacture thereof, and to the use of the stipulated salts to improve mildness is also described.03-22-2012